203 related articles for article (PubMed ID: 23933116)
1. Ribonucleotide reductase inhibitors hydroxyurea, didox, and trimidox inhibit human cytomegalovirus replication in vitro and synergize with ganciclovir.
Bhave S; Elford H; McVoy MA
Antiviral Res; 2013 Oct; 100(1):151-8. PubMed ID: 23933116
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects by combination of ganciclovir and tricin on human cytomegalovirus replication in vitro.
Yamada R; Suda H; Sadanari H; Matsubara K; Tuchida Y; Murayama T
Antiviral Res; 2016 Jan; 125():79-83. PubMed ID: 26640224
[TBL] [Abstract][Full Text] [Related]
3. In vitro co-infection by cytomegalovirus improves the antiviral activity of ganciclovir against human adenovirus.
Aguilar-Guisado M; Marrugal-Lorenzo JA; Berastegui-Cabrera J; Merino L; Pachón J; Sánchez-Céspedes J
Int J Antimicrob Agents; 2020 Aug; 56(2):106046. PubMed ID: 32540429
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ganciclovir-resistant human cytomegalovirus replication by Kampo (Japanese herbal medicine).
Murayama T; Yamaguchi N; Iwamoto K; Eizuru Y
Antivir Chem Chemother; 2006; 17(1):11-6. PubMed ID: 16542001
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of hemoglobin and F-cell production by targeting growth inhibition and differentiation of K562 cells with ribonucleotide reductase inhibitors (didox and trimidox) in combination with streptozotocin.
Iyamu WE; Adunyah SE; Fasold H; Horiuchi K; Elford HL; Asakura T; Turner EA
Am J Hematol; 2000 Apr; 63(4):176-83. PubMed ID: 10706760
[TBL] [Abstract][Full Text] [Related]
6. Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase.
Tenney DJ; Yamanaka G; Voss SM; Cianci CW; Tuomari AV; Sheaffer AK; Alam M; Colonno RJ
Antimicrob Agents Chemother; 1997 Dec; 41(12):2680-5. PubMed ID: 9420038
[TBL] [Abstract][Full Text] [Related]
7. 2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (1110U81) potently inhibits human cytomegalovirus replication and potentiates the antiviral effects of ganciclovir.
Hamzeh FM; Spector T; Lietman PS
Antimicrob Agents Chemother; 1993 Mar; 37(3):602-4. PubMed ID: 8384821
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections.
Hostetler KY; Rybak RJ; Beadle JR; Gardner MF; Aldern KA; Wright KN; Kern ER
Antivir Chem Chemother; 2001 Jan; 12(1):61-70. PubMed ID: 11437323
[TBL] [Abstract][Full Text] [Related]
9. Interaction of gallium nitrate with other inhibitors of ribonucleotide reductase: effects on the proliferation of human leukemic cells.
Myette MS; Elford HL; Chitambar CR
Cancer Lett; 1998 Jul; 129(2):199-204. PubMed ID: 9719462
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Cytomegalovirus Replication with Extended-Half-Life Synthetic Ozonides.
Wang Y; Mukhopadhyay R; Roy S; Kapoor A; Su YP; Charman SA; Chen G; Wu J; Wang X; Vennerstrom JL; Arav-Boger R
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373792
[TBL] [Abstract][Full Text] [Related]
11. In vivo examination of hydroxyurea and the novel ribonucleotide reductase inhibitors trimidox and didox in combination with the reverse transcriptase inhibitor abacavir: suppression of retrovirus-induced immunodeficiency disease.
Sumpter LR; Inayat MS; Yost EE; Duvall W; Hagan E; Mayhew CN; Elford HL; Gallicchio VS
Antiviral Res; 2004 Jun; 62(3):111-20. PubMed ID: 15130534
[TBL] [Abstract][Full Text] [Related]
12. Synergistic enhancement of herpes simplex virus thymidine kinase/ganciclovir-mediated cytoxicity by hydroxyurea.
Boucher PD; Ostruszka LJ; Shewach DS
Cancer Res; 2000 Mar; 60(6):1631-6. PubMed ID: 10749133
[TBL] [Abstract][Full Text] [Related]
13. NUDT15-mediated hydrolysis limits the efficacy of anti-HCMV drug ganciclovir.
Zhang SM; Rehling D; Jemth AS; Throup A; Landázuri N; Almlöf I; Göttmann M; Valerie NCK; Borhade SR; Wakchaure P; Page BDG; Desroses M; Homan EJ; Scobie M; Rudd SG; Berglund UW; Söderberg-Nauclér C; Stenmark P; Helleday T
Cell Chem Biol; 2021 Dec; 28(12):1693-1702.e6. PubMed ID: 34192523
[TBL] [Abstract][Full Text] [Related]
14. Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood.
Baldanti F; Simoncini L; Sarasini A; Zavattoni M; Grossi P; Revello MG; Gerna G
Transplantation; 1998 Aug; 66(3):324-9. PubMed ID: 9721800
[TBL] [Abstract][Full Text] [Related]
15. Comparison of human cytomegalovirus DNA polymerase activity for ganciclovir-resistant and -sensitive clinical strains.
Kariya M; Mori S; Eizuru Y
Antiviral Res; 2000 Feb; 45(2):115-22. PubMed ID: 10809020
[TBL] [Abstract][Full Text] [Related]
16. Resistance to a Nucleoside Analog Antiviral Drug from More Rapid Extension of Drug-Containing Primers.
Chen H; Lawler JL; Filman DJ; Hogle JM; Coen DM
mBio; 2021 Feb; 12(1):. PubMed ID: 33563814
[TBL] [Abstract][Full Text] [Related]
17. An in silico-designed flavone derivative, 6-fluoro-4'-hydroxy-3',5'-dimetoxyflavone, has a greater anti-human cytomegalovirus effect than ganciclovir in infected cells.
Fujimoto KJ; Nema D; Ninomiya M; Koketsu M; Sadanari H; Takemoto M; Daikoku T; Murayama T
Antiviral Res; 2018 Jun; 154():10-16. PubMed ID: 29559264
[TBL] [Abstract][Full Text] [Related]
18. Effective use of ribonucleotide reductase inhibitors (Didox and Trimidox) alone or in combination with didanosine (ddI) to suppress disease progression and increase survival in murine acquired immunodeficiency syndrome (MAIDS).
Mayhew C; Oakley O; Piper J; Hughes NK; Phillips J; Birch NJ; Elford HL; Gallicchio VS
Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):1019-29. PubMed ID: 9449534
[TBL] [Abstract][Full Text] [Related]
19. In vitro antiviral efficacy of the ganciclovir complexed with beta-cyclodextrin on human cytomegalovirus clinical strains.
Nicolazzi C; Venard V; Le Faou A; Finance C
Antiviral Res; 2002 May; 54(2):121-7. PubMed ID: 12062397
[TBL] [Abstract][Full Text] [Related]
20. Combination of inhibitors of lymphocyte activation (hydroxyurea, trimidox, and didox) and reverse transcriptase (didanosine) suppresses development of murine retrovirus-induced lymphoproliferative disease.
Mayhew CN; Sumpter R; Inayat M; Cibull M; Phillips JD; Elford HL; Gallicchio VS
Antiviral Res; 2005 Jan; 65(1):13-22. PubMed ID: 15652967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
